SL
Sandeep Laxminaray Zanwar
About Sandeep Laxminaray Zanwar
Data last updated:
Sandeep Laxminaray Zanwar has 17 years in corporate governance. Holds Director role. Currently with 1 company, including Bayberry Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Bayberry Pharmaceuticals Private Limited at ₹18.82 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bayberry Pharmaceuticals Private Limited U24230PN2009PTC133910 | Director | 07 May 2009 | 2009 | ₹18.82 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sandeep Laxminaray Zanwar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sandeep Laxminaray Zanwar
Sandeep Laxminaray Zanwar has 17 years in corporate governance. Holds Director role. Currently with 1 company, including Bayberry Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Bayberry Pharmaceuticals Private Limited at ₹18.82 Cr (FY 2025).
Sandeep Laxminaray Zanwar is associated with 1 company as Director, including Bayberry Pharmaceuticals Private Limited (₹18.82 Cr).
Sandeep Laxminaray Zanwar has expertise in General Business.
Sandeep Laxminaray Zanwar has 17 years in corporate governance.
By reported revenue, the largest current company of Sandeep Laxminaray Zanwar is Bayberry Pharmaceuticals Private Limited, with revenue of ₹18.82 Cr (FY 2025).
Sandeep Laxminaray Zanwar currently holds positions at 1 company: Bayberry Pharmaceuticals Private Limited (₹18.82 Cr).